RxDoctor Payments Data

David Winters, DO

Family Medicine · Ooltewah, TNNPI 1912984576

Payments from drug & device makers

$7,304in general payments, 2019–2025

Across 443 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$873
  • Amgen$577
  • Pfizer$576
  • Johnson & Johnson$468
  • Astellas Pharma US Inc$408
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$7,18298%
  • Education$1081%
  • Entertainment$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,304 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$124,758
Medicare patients
480
Services billed
4,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban264$122,155
OzempicSemaglutide48$64,450
XifaxanRifaximin14$48,292
RybelsusSemaglutide29$47,557
TrulicityDulaglutide21$43,090
NuplazidPimavanserin Tartrate32$41,023
JardianceEmpagliflozin25$23,309
XareltoRivaroxaban35$21,392
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$19,101
Repatha SureclickEvolocumab25$17,778
JanuviaSitagliptin Phosphate11$11,508
TradjentaLinagliptin24$10,610
FarxigaDapagliflozin Propanediol15$8,596
Breo ElliptaFluticasone/Vilanterol16$8,152
Tresiba Flextouch U-100Insulin Degludec15$8,149

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$576$122,155264 claims
Novo NordiskOzempic, Rybelsus, Novolog$1,325$113,71396 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$285$48,29214 claims
Lilly USA, LLCTrulicity$156$43,09021 claims
Boehringer IngelheimJardiance, Tradjenta$247$33,91949 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$87$32,26553 claims
Johnson & JohnsonXarelto$468$21,39235 claims
MerckJanuvia$135$11,50811 claims
AstraZenecaFarxiga$873$8,59615 claims
Astellas Pharma US IncMyrbetriq$408$7,36413 claims
AbbVieSynthroid$209$4,24238 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Ooltewah

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →